Bristol Myers Squibb clinches acquisition of Forbius
Adds phase 1 isoform-selective TGF-beta inhibitor AVID200 to pipeline
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Samsung Biologics and AstraZeneca sign manufacturing deal for $330.8 million
Samsung Biologics will provide large-scale commercial manufacturing for drug substance in its Plant 3 as well as drug product to…
Haryana showcases readiness to bid for bulk drugs and medical device parks at PHDCCI webinar
Outlines attractions that the State will offer investors to ensure ease of doing business
SPARC signs license agreement with Tripoint Therapeutics for Elepsia XR tablets
SPARC will be eligible to receive tiered royalties ranging from 15 per cent to 50 per cent on net sales
ARCA biopharma submits IND application to US FDA for a potential COVID-19 treatment
Pending FDA feedback, ARCA anticipates initiating the Phase 2b portion of a sequential Phase 2b/3 clinical evaluation of AB201 in…
BDR Pharma launches 80mg of Enzalutamide for prostate cancer treatment
BDR Pharmaceutical has launched 80mg advanced version of its Enzalutamide drug. Earlier the company had received the approval from…
analytica Anacon India & India Lab Expo Hyderabad edition to be held in Sept, 2021
analytica Anacon India and India Lab Expo will bring together professionals from various verticals to foster businesses globally…
Scientists find new drug that may be able to prevent or mitigate severe COVID-19 infection
Repurposing the 4-PBA anti-stress drug could modulate such cellular stress and curb mortality caused by respiratory failure…
Developing herd immunity without pharma interventions may have detrimental consequences: Choubey
Thirteen clinical trials of repurposed drugs have been undertaken to build a portfolio of therapeutic options for COVID-19…
LSV Capital to invest $70 million for Indian healthcare, life sciences start-ups
Sets up its first office in Bengaluru, to hire senior-level associates in life sciences to join its India office which will be…